TCL1A and B-cell chronic lymphocytic leukemia: Remarkably, ts-53 targets the 3′UTR of TCL1, and its downregulation in CLL is inversely correlated with TCL1 expression, suggesting that tsRNAs can control gene expression post-transcriptionally [24].